| RS1135402912 |
MAGI2
|
Health Risk |
Pathogenic |
Nephrotic syndrome 15, Nephrotic syndrome 15 |
| RS1135402913 |
MAGI2
|
Health Risk |
Pathogenic |
Nephrotic syndrome 15, Nephrotic syndrome 15 |
| RS1135402914 |
CD55
|
Health Risk |
Pathogenic |
CROMER BLOOD GROUP SYSTEM, Dr(a-) PHENOTYPE |
| RS1135402915 |
CD55
|
Health Risk |
Pathogenic |
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome, Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome |
| RS1135402916 |
CD55
|
Health Risk |
Pathogenic |
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome, Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome |
| RS1135402917 |
CD55
|
Health Risk |
Pathogenic |
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome, Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome |
| RS1135402918 |
CD55
|
Health Risk |
Pathogenic |
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome, Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome |
| RS113541584 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS113542001 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiomyopathy |
| RS113542201 |
SLC29A3
|
Health Risk |
Conflicting classifications of pathogenicity |
H syndrome, SLC29A3-related disorder |
| RS113543334 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113544411 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113544635 |
MYO1E
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO1E-related disorder, MYO1E-related disorder |
| RS113547523 |
AKT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 6, Proteus syndrome |
| RS113548014 |
ARID2
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 6, Coffin-Siris syndrome 6 |
| RS113549339 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated focal cortical dysplasia type II, Tuberous sclerosis 1 |
| RS113552091 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 14 |
| RS113555227 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
FREM1-related disorder, FREM1-related disorder |
| RS113560320 |
SDHAF2
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 2, Hereditary cancer-predisposing syndrome |
| RS113562492 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease |
| RS113566014 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Genitopatellar syndrome |
| RS113570783 |
PDZD7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113571926 |
IL17RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 51, Immunodeficiency 51 |
| RS113577450 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS113582618 |
KRT14
|
Health Risk |
Pathogenic |
— |
| RS113583033 |
GPAA1
|
Health Risk |
Likely pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 15, Glycosylphosphatidylinositol biosynthesis defect 15 |
| RS113584704 |
PI4KA
|
Health Risk |
Conflicting classifications of pathogenicity |
Polymicrogyria, perisylvian |
| RS113587712 |
NPC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS113587743 |
OGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Oxoglutaricaciduria, Oxoglutaricaciduria |
| RS113591604 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS113593896 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta |
| RS113594027 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS113594178 |
FDXR
|
Health Risk |
Conflicting classifications of pathogenicity |
FDXR-related disorder, Inborn genetic diseases |
| RS113595574 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS113596176 |
TRIP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113597796 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS113602180 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113602485 |
GRHPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrolithiasis/nephrocalcinosis, Primary hyperoxaluria |
| RS113603747 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS113604000 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS113604459 |
FBN1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Marfan syndrome |
| RS113605136 |
COL6A3
|
Health Risk |
Likely pathogenic |
— |
| RS113605768 |
RIPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS113605875 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 1, Cardiovascular phenotype |
| RS113607507 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS113610699 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Hepatocellular carcinoma |
| RS113612402 |
TPM2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS113614842 |
SALL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Townes-Brocks syndrome 1, Townes syndrome |
| RS113616418 |
DNAH17
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DNAH17-related disorder |
| RS113617037 |
TNNT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy, Nemaline myopathy |
| RS113617771 |
SPARC
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, SPARC-related disorder |
| RS113624323 |
LAMA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa gravis of Herlitz, Laryngo-onycho-cutaneous syndrome |
| RS113624356 |
BBS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS113625622 |
TTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyloidosis, hereditary systemic 1 |
| RS113631419 |
NLRC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Periodic fever-infantile enterocolitis-autoinflammatory syndrome, Familial cold autoinflammatory syndrome 4 |
| RS113632824 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, DUOX2-related disorder |
| RS113638388 |
GAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities |
| RS113642086 |
COG8
|
Health Risk |
Conflicting classifications of pathogenicity |
COG8-congenital disorder of glycosylation, COG8-congenital disorder of glycosylation |
| RS113643181 |
ATP13A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS113645893 |
ARG1
|
Health Risk |
Likely pathogenic |
Arginase deficiency, Arginase deficiency |
| RS113646094 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113651836 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Brain small vessel disease 1 with or without ocular anomalies |
| RS113651985 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS113652023 |
ALG12
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG12-congenital disorder of glycosylation, ALG12-congenital disorder of glycosylation |
| RS113652076 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS113656989 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS113660545 |
COG5
|
Health Risk |
Conflicting classifications of pathogenicity |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS113663584 |
PTCH1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS113667224 |
MYH11;NDE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 6 |
| RS113668504 |
C1QTNF3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113669610 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS113669789 |
TMEM70
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS113673055 |
DOCK2
|
Health Risk |
Conflicting classifications of pathogenicity |
DOCK2 deficiency, DOCK2-related disorder |
| RS113673597 |
BAAT
|
Health Risk |
Conflicting classifications of pathogenicity |
BAAT-related disorder, BAAT-related disorder |
| RS113676750 |
PTPRB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113678603 |
MOCS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, MOCS1-related disorder |
| RS113679696 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS113681235 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS113683179 |
FN1
|
Health Risk |
Pathogenic |
Spondylometaphyseal dysplasia - Sutcliffe type, Spondylometaphyseal dysplasia - Sutcliffe type |
| RS113684274 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS113688475 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
OTOG-related disorder, Autosomal recessive nonsyndromic hearing loss 18B |
| RS113689741 |
NHEJ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cernunnos-XLF deficiency, NHEJ1-related disorder |
| RS113689961 |
SMS
|
Health Risk |
Likely pathogenic |
SMS-related disorder, SMS-related disorder |
| RS113690956 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS113693945 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113695103 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113695182 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113695558 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS113696032 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS113697235 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS113697814 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS113698006 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, ABCA4-related disorder |
| RS113700354 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS113702075 |
SBF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4B2, Charcot-Marie-Tooth disease type 4B2 |
| RS113705469 |
TGM1
|
Health Risk |
Likely pathogenic |
— |
| RS113706344 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Inflammatory bowel disease 1 |
| RS113709347 |
CNTN2
|
Health Risk |
Likely pathogenic |
Epilepsy, familial adult myoclonic |
| RS113709679 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS113712384 |
RBP4
|
Health Risk |
Likely pathogenic |
— |
| RS113716139 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |